HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TYK MEDICINES-B

14.210

-0.590-3.99%

Volume:4.15M

Turnover:58.98M

Market Cap:5.40B

PE:-11.37

High:14.970

Open:14.970

Low:14.000

Close:14.800

52wk High:56.550

52wk Low:13.000

Shares:380.07M

HK Float Shares:375.46M

Volume Ratio:0.61

T/O Rate:1.11%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.250

ROE:--

ROA:-27.71%

PB:13.87

PE(LYR):-11.37

PS:46274.07

Loading ...

Overview Company News Filings

TYK Medicines' Cancer Drug Accepted for Mini Oral Presentation at Medical Conference

MT Newswires Live

TYK Medicines Inc. Completes Private Placement of New H Shares Under General Mandate

TYK Medicines Inc. Announces Private Placement of 9.23 Million H Shares at HK$17.01 Each

Tyk Medicines - Placing of 9.2 Mln H Sharers at HK$17.01 per Share

THOMSON REUTERS

TYK Medicines Inc. Announces Phase I Clinical Trial Results for TY-302, TY-2699a, and TY-0540 Accepted for Presentation at ESMO Congress 2025

HK Movers | Biotech Stocks Rally, Ascent Led by TYK Medicines and Sirnaomics

Tiger Newspress

TYK Medicines Inc. Held Annual General Meeting

TYK Medicines' VP Steps Down

MT Newswires Live

BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive Director

TYK Medicines Included in Hang Seng Biotech Index

MT Newswires Live

BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up

TYK Medicines Inc. Joins Hang Seng Biotech Index

TYK Medicines Inc. Proposes Appointment of Dr. Zhu Xiangyang as Non-Executive Director

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02410/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":14.21,"timestamp":1761206895003,"preClose":14.8,"halted":0,"volume":4151000,"delay":0,"floatShares":375457818,"shares":380065818,"eps":-1.2501690716628326,"marketStatus":"Not Yet Opened","change":-0.59,"latestTime":"10-23 16:08:15","open":14.97,"high":14.97,"low":14,"amount":58980035,"amplitude":0.065541,"askPrice":14.23,"askSize":29500,"bidPrice":14.21,"bidSize":14000,"shortable":3,"etf":0,"ttmEps":-0.8419325682588287,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1761269400000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":14.8,"openAndCloseTimeList":[[1761183000000,1761192000000],[1761195600000,1761206400000]],"volumeRatio":0.6129897353800561,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-27.71%","roe":"--","lyrEps":-1.250169,"volumeRatio":0.6129897353800561,"shares":380065818,"dividePrice":0,"high":14.97,"amplitude":0.065541,"preClose":14.8,"low":14,"week52Low":13,"pbRate":"13.87","psRate":"46274.07","week52High":56.55,"institutionHeld":0,"latestPrice":14.21,"committee":-0.356322,"eps":-1.2501690716628326,"divideRate":0,"volume":4151000,"delay":0,"ttmEps":-0.8419325682588287,"open":14.97,"prevYearClose":47.15,"prevWeekClose":15.38,"prevMonthClose":16.54,"prevQuarterClose":16.54,"fiveDayClose":16.11,"twentyDayClose":16.1,"sixtyDayClose":21.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747411200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-10-22","current":-16.877836,"percent":0.665517,"low":-45.171338,"twenty":-25.404765,"median":-19.98121,"eighty":-16.767615,"high":-10.104382,"avg":-21.978317,"sd":6.401716,"marketCap":5624974106},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-22","current":-18.413199,"twenty":-25.404765,"median":-19.98121,"eighty":-16.767615,"marketCap":5624974106}],"updateTime":1761254785060},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559933659","title":"TYK Medicines' Cancer Drug Accepted for Mini Oral Presentation at Medical Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2559933659","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559933659?lang=en_us&edition=fundamental","pubTime":"2025-08-14 09:53","pubTimestamp":1755136433,"startTime":"0","endTime":"0","summary":"TYK Medicines  said the results from a mid-stage study of its experimental cancer drug TY-9591 were accepted for mini oral presentation at the World Conference on Lung Cancer, according to a Thursday filing with the Hong Kong bourse.The company will present interim results from the Esaona phase 2 study in subjects with EGFR-mutant non-small cell lung cancer.The study is examining how well TY-9591, or asandeutertinib, works when compared to osimertinib in previously untreated patients.Based on data available as of Feb. 28, asandeutertinib had a superior objective response rate of 84.7% versus osimertinib's 75.2% in patients whose cancer had spread to the brain, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02410","BK1161","MDCO"],"gpt_icon":0},{"id":"2556538045","title":"TYK Medicines Inc. Completes Private Placement of New H Shares Under General Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=2556538045","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556538045?lang=en_us&edition=fundamental","pubTime":"2025-08-04 22:45","pubTimestamp":1754318752,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. has announced the completion of a placement of new H shares under a general mandate. The company successfully fulfilled all conditions set out in the Placing Agreement, with the completion taking place recently. The net proceeds from the placement will be allocated towards several strategic goals: approximately 60% for research, development, and commercialization of existing pipelines; 30% for enhancing internal R&D technology capabilities and expanding the product portfolio; and 10% for working capital and general corporate purposes. This move is expected to bolster TYK Medicines' position in the pharmaceutical industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL9FYyrB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2555423704","title":"TYK Medicines Inc. Announces Private Placement of 9.23 Million H Shares at HK$17.01 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2555423704","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555423704?lang=en_us&edition=fundamental","pubTime":"2025-07-29 06:09","pubTimestamp":1753740544,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc., a joint stock company incorporated in the People's Republic of China, has announced a private placement involving the issuance of 9,230,000 new H shares under a general mandate. The company has entered into a Placing Agreement with a Placing Agent, who will act on a best effort basis to procure Placees to purchase the shares at a price of HK$17.01 per share. This issuance represents approximately 2.52% of the company's total issued shares. The expected closing date for the placement is August 5, 2025, subject to conditions being met. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL3F97RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2555070444","title":"Tyk Medicines -  Placing of 9.2 Mln H Sharers at HK$17.01 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2555070444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555070444?lang=en_us&edition=fundamental","pubTime":"2025-07-29 06:08","pubTimestamp":1753740495,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nFWN3TP1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2553789613","title":"TYK Medicines Inc. Announces Phase I Clinical Trial Results for TY-302, TY-2699a, and TY-0540 Accepted for Presentation at ESMO Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789613","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553789613?lang=en_us&edition=fundamental","pubTime":"2025-07-24 22:48","pubTimestamp":1753368488,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. Announces Phase I Clinical Trial Results for TY-302, TY-2699a, and TY-0540 Accepted for Presentation at ESMO Congress 2025. TYK Medicines Inc. has announced that the Phase I clinical trial results for its internally-developed products, TY-302, TY-2699a, and TY-0540, have been accepted for poster presentation at the upcoming 2025 European Society for Medical Oncology  Congress. The ESMO Congress, a leading international event in the field of oncology, will take place from October 17 to 21 in Berlin, Germany. The company will present detailed data from these trials during the conference, which involves studies on various cancers, including breast and ovarian cancer. Acceptance for presentation at this prestigious event signifies notable international academic recognition of TYK Medicines' research and development efforts. The company has advised shareholders and potential investors to exercise caution when dealing with its shares, as there is no guaranteed successful d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL2Qlcly:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"1105365585","title":"HK Movers | Biotech Stocks Rally, Ascent Led by TYK Medicines and Sirnaomics","url":"https://stock-news.laohu8.com/highlight/detail?id=1105365585","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105365585?lang=en_us&edition=fundamental","pubTime":"2025-07-24 10:18","pubTimestamp":1753323516,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biotech stocks jumped on Thursday. TYK Medicines surged over 15%, while Sirnaomics climbed more than 13%. CanSino Biologics rose more than 7%, Everest Medicines and Akeso advanced...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a4002f3d59c45e75b4534d9376b8dfdb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","09926","02410","06185","02257"],"gpt_icon":0},{"id":"2546173370","title":"TYK Medicines Inc. Held Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546173370","media":"Reuters","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546173370?lang=en_us&edition=fundamental","pubTime":"2025-06-26 20:51","pubTimestamp":1750942276,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. held its 2024 Annual General Meeting on June 26, 2025. During the meeting, the Report of the Directors for the year 2024 was approved. Additionally, the Report of the Board of Supervisors for the year 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on June 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDLbNh08y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2538677466","title":"TYK Medicines' VP Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2538677466","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538677466?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:14","pubTimestamp":1748348051,"startTime":"0","endTime":"0","summary":"Jiang Mingyu resigned as TYK Medicines'  vice president among other roles effective June 13 to devote more time to other business engagements, a Tuesday Hong Kong bourse filing said.Jiang will also be re-designated from an executive director to a non-executive director of the pharmaceutical company effective the same day.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02410","MDCO"],"gpt_icon":0},{"id":"2538454070","title":"BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2538454070","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538454070?lang=en_us&edition=fundamental","pubTime":"2025-05-27 17:46","pubTimestamp":1748339167,"startTime":"0","endTime":"0","summary":"BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive DirectorMay 27 (Reuters) - TYK Medicines Inc 2410.HK:JIANG MINGYU WOULD BE RE-DESIGNATED FROM EXECUTIVE DIRECTOR TO NON-EXECUTIVE DIRECTORFurther company coverage: 2410.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RY0WB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2536683922","title":"TYK Medicines Included in Hang Seng Biotech Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2536683922","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536683922?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:44","pubTimestamp":1747651499,"startTime":"0","endTime":"0","summary":"TYK Medicines' (HKG:2410) H shares were selected for inclusion in the Hang Seng Biotech Index effective June 9, a Monday Hong Kong bourse filing said.The Hang Seng Biotech Index aims to reflect the overall performance of Hong Kong listed biotech companies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02410","BK1161","MDCO"],"gpt_icon":0},{"id":"2536526374","title":"BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up","url":"https://stock-news.laohu8.com/highlight/detail?id=2536526374","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536526374?lang=en_us&edition=fundamental","pubTime":"2025-05-19 11:11","pubTimestamp":1747624270,"startTime":"0","endTime":"0","summary":"BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up** Shares of online literature and intellectual property incubation platform China Literature 0772.HK drop 8.3% to HK$24.20, their lowest since April 9** Stock on course for its biggest one-day pct decline since April 7; top pct loser on Hang Seng Tech Index .HSTECH, which falls 1%** Index compiler Hang Seng Indexes Co Ltd said on Friday China Literature will be removed from Hang Seng Tech Index .HSTECH, while BYD Co 1211.HK will be included in the index from June 9 ** Midea Group 0300.HK and ZTO Express 2057.HK will be added to the Hang Seng Index .HSI, increasing the number of constituents to 85 from 83** Shares of Midea and ZTO climb 1.8% and 3.7%, respectively** TYK Medicines 2410.HK and Kangji Medical 9997.HK will be added to Hang Seng Biotech Index .HSHKBIO, while Alphamab Oncology 9966.HK and RemeGen 9995.HK will be removed from the index** TYK and Kangji rise as much as 2.4% and 4.2%, respectively   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c713467fa5347bab03b18f7285ed8f71","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nL1N3RR024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2249611893.SGD","IE00B031HW06.USD","LU0819123356.HKD","EVS.SI","BK0187","000333","HTCD.SI","LU2399975544.HKD","00300","LU0918141887.USD","BYDDY","LU0235996351.USD","LU0823397285.USD","BK1522","LU0955669360.SGD","09995","LU1820825898.SGD","LU0502904849.HKD","BK1540","81211","LU0611395673.USD","LU0127658192.USD","LU2506951792.HKD","688331","BK1521","LU1130305938.SGD","LU0348783662.USD","HYDD.SI","LU0572939691.SGD","IE00BPRC5H50.USD","02057","LU0588545730.USD","02410","LU1997244956.HKD","00772","002594","09997","TCHmain","09966","SG9999001846.SGD","LU1770036033.HKD","SG9999013353.USD","LU0348735423.USD","LU0049853897.USD","LU0181495838.USD","LU0231483743.USD","LU2362541513.USD","LU0531971595.HKD"],"gpt_icon":1},{"id":"2536651083","title":"TYK Medicines Inc. Joins Hang Seng Biotech Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2536651083","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536651083?lang=en_us&edition=fundamental","pubTime":"2025-05-19 08:01","pubTimestamp":1747612913,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. is set to be added to the Hang Seng Biotech Index, effective June 9, 2025. The inclusion reflects the capital market's recognition of the company's business performance and growth outlook.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL560kcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2535520395","title":"TYK Medicines Inc. Proposes Appointment of Dr. Zhu Xiangyang as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2535520395","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535520395?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:05","pubTimestamp":1747393504,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. has announced a proposed appointment of Dr. Zhu Xiangyang as a non-executive director. The decision is pending approval from shareholders at the upcoming annual general meeting scheduled for June 26, 2025. Dr. Zhu, aged 64, brings over 20 years of experience in the biopharmaceutical industry and is currently serving as a consultant to the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL1yRLm2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}]}}